Buyback Spend for STERIS (STE)
Buyback Spend for STERIS (STE): headline value $207.26M · YoY +1696.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
STE
Currently viewingBuyback SpendSwitch metric
Latest period
$207.26M
YoY change
+1696.2%
5Y CAGR
+32.8%
Peak year (2023)
$308.56M
Latest annual
$211.32M
Buyback Spend history chart for STERIS (STE) from 1991 to 2025
Buyback Spend history table for STERIS (STE) from 1991 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $211.32M | +1696.2% | ||
| 2024 | $11.77M | -96.2% | ||
| 2023 | $308.56M | +453.2% | ||
| 2022 | $55.78M | +280.8% | ||
| 2021 | $14.65M | -71.4% | ||
| 2020 | $51.24M | -37.1% | ||
| 2019 | $81.49M | +24.4% | ||
| 2018 | $65.48M | -32.8% | ||
| 2017 | $97.51M | +578.6% | ||
| 2016 | $14.37M | -53.2% | ||
| 2015 | $30.69M | +20.5% | ||
| 2014 | $25.47M | +218.3% | ||
| 2013 | $8.00M | -85.9% | ||
| 2012 | $56.75M | +89.4% | ||
| 2011 | $29.96M | +9566.1% | ||
| 2010 | $310,000 | -99.6% | ||
| 2009 | $80.47M | -54.6% | ||
| 2008 | $177.17M | +194.5% | ||
| 2007 | $60.17M | -28.5% | ||
| 2006 | $84.15M | +148.5% | ||
| 2005 | $33.87M | +103.9% | ||
| 2004 | $16.61M | +3.4% | ||
| 2003 | $16.07M | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | -100.0% | ||
| 2000 | $28.71M | +62.2% | ||
| 1999 | $17.70M | +75.2% | ||
| 1998 | $10.10M | -11.4% | ||
| 1997 | $11.40M | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — |
Buyback Spend values are taken from STERIS's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, STERIS (STE) reported buyback spend of $211.32M – surged 1696.2% year-over-year.
Through 2020–2025 (5 years), STERIS buyback spend delivered a +32.8% annualised rate; with the latest reading among the more recent periods of the dataset.
STERIS buyback spend peaked at $308.56M in 2023; the latest annual figure is $211.32M in 2025 (31.5% below peak).
Across the available history, buyback spend reached its high of $308.56M in 2023 and its low of $0 in 1991.
Within Healthcare, STERIS (STE) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.
STERIS Buyback Spend by Year
STERIS Buyback Spend 2025: $211.32M
STERIS buyback spend in 2025 was $211.32M, surged 1696.2% from 2024.
STERIS Buyback Spend 2024: $11.77M
STERIS buyback spend in 2024 was $11.77M, plunged 96.2% below 2023.
STERIS Buyback Spend 2023: $308.56M
STERIS buyback spend in 2023 was $308.56M, surged 453.2% from 2022. This figure represents the highest annual value in the available history.
STERIS Buyback Spend 2022: $55.78M
STERIS buyback spend in 2022 was $55.78M, surged 280.8% from 2021.
STERIS Buyback Spend 2021: $14.65M
STERIS buyback spend in 2021 was $14.65M.
See more financial history for STERIS (STE).
Sector peers — Buyback Spend
Companies in the same sector as STERIS, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is STERIS's buyback spend?
Latest reported buyback spend for STERIS (STE) is $207.26M (period ending December 31, 2025).
How has STERIS buyback spend changed year-over-year?
STERIS (STE) buyback spend changed +1696.2% year-over-year on the latest annual filing.
What is the long-term growth rate of STERIS buyback spend?
STERIS (STE) buyback spend compound annual growth rate is +32.8% over the most recent 5 years available.
When did STERIS buyback spend hit its highest annual value?
STERIS buyback spend reached its highest annual value of $308.56M in 2023.
What was STERIS buyback spend in 2024?
STERIS (STE) buyback spend in 2024 was $11.77M.
What was STERIS buyback spend in 2025?
STERIS (STE) buyback spend in 2025 was $211.32M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
STE Overview
Company profile, financial tools, and key metrics
STE Revenue Counter
Earns $184.81 every second. See per minute, hour, and day.
STE Earnings Counter
Earns $22.44 per second net profit. See per minute, hour, and day.
STE Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
STE What If Invested
What if you had invested $1,000? See historical returns from any date.
STE How It Makes Money
Discover visual breakdown of $5.83B in revenue — where it comes from and where it goes.
STE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
STE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
STE Daily Price Character
Balanced · 49.9% historical win rate (green days). Streaks & record days.
STE Buybacks
0.83% TTM buyback yield. Shareholder yield & SBC comparison.
STE Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
STE Dividend Profile
Yield: 1.16%. Safety: 7/7. See full history.
STE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
STE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.